Comparable stake leader
EVENTIDE ASSET MANAGEMENT, LLC
SEC ownership of Beta Bionics, Inc.
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001674632.
Disclosed value leader
EVENTIDE ASSET MANAGEMENT, LLC
Comparable rows
50/50
Latest evidence
17 Jul 2026
- Public ticker
- BBNX on Nasdaq
- Parsed ownership sources
-
13F, 13D/G, and 3/4/5
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
- Largest SEC-reported holder
-
EVENTIDE ASSET MANAGEMENT, LLC
Ranking: Comparable ownership first, then disclosed value
- Comparable ownership rows
-
50 of 50
Meaning: Rows with safely comparable ownership %
- Latest 13D/G holder
-
EVENTIDE ASSET MANAGEMENT, LLC
Source: Latest parsed Schedule 13D/G stake
- Latest parsed ownership date
-
17 Jul 2026
Freshness: Most recent filing date in this holder set
- Issuer CIK
- 0001674632
- Issuer location
- Irvine, CA
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
3 signals
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of Beta Bionics, Inc. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
EVENTIDE ASSET MANAGEMENT...
Disclosed value leader
EVENTIDE ASSET MANAGEMENT...
Comparable rows
50/50
Latest evidence
17 Jul 2026
13F
13D/G
3/4/5
Lead comparable stake: 13%
13D/G row: EVENTIDE ASSET MANAGEMENT, LLC
Showing 1-8 of 50 holder rows.
Quick read
EVENTIDE ASSET MANAGEMENT, LLC leads the comparable SEC ownership view at 13%.
50 of 50 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens EVENTIDE ASSET MANAGEMENT, LLC's linked filing trail.
Comparable ownership
Top 5
EVENTIDE ASSET MANAGEMENT, LLC
13%
Zone Healthcare Holdings, LLC
9.9%
Soleus Capital Group, LLC
9.8%
MORGAN STANLEY
8.6%
Sands Capital Life Sciences Pulse...
8.2%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-8 of 50 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| EVENTIDE ASSET MANAGEMENT, LLC |
13F
13D/G
Company
|
13%
from 13D/G
|
$98,053,951
6,253,673 shares
|
— | 30 Jun 2026 |
| Zone Healthcare Holdings, LLC |
13D/G
Dapice Joshua J.
|
9.9%
|
$85,717,590
4,313,920 shares
|
+$17,618,729 | 30 Sep 2025 |
| Soleus Capital Group, LLC |
13D/G
Levy Guy
|
9.8%
|
$38,580,879
4,354,501 shares
|
$0 | 31 Mar 2026 |
| MORGAN STANLEY |
13D/G
13F
Company
|
8.6%
|
$74,305,196
3,739,567 shares
|
+$16,109,185 | 30 Sep 2025 |
| Sands Capital Life Sciences Pulse Fund II, L.P. |
13D/G
|
8.2%
|
$48,410,732
3,570,113 shares
|
+$5,636,946 | 30 Jun 2025 |
| Farallon Capital Partners, L.P. |
13D/G
Dapice Joshua J.
|
8.1%
|
$31,966,171
3,607,920 shares
|
-$6,839,920 | 31 Mar 2026 |
| Divisadero Street Capital Management, LP |
13D/G
13F
Company
|
6.9%
|
$48,154,597
3,072,985 shares
|
$0 | 17 Jul 2026 |
| BlackRock, Inc. |
13D/G
13F
Company
|
6.4%
|
$55,215,708
2,778,764 shares
|
$0 | 30 Sep 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Net insider flow leans to selling over the last 12 months. Net value: -$4,046,782.
Buys
$0
Insiders: 0
Sells
$4,046,782
Insiders: 8
Net
-$4,046,782
Shares: -203,661
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 0
Shares: 203,661
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 93,415 | $0 | $1,732,440 | -$1,732,440 |
| 3-6 | 0 | 44,559 | $0 | $556,233 | -$556,233 |
| 6-9 | 0 | 30,353 | $0 | $891,935 | -$891,935 |
| 9-12 | 0 | 35,334 | $0 | $866,173 | -$866,173 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-12 of 12 reporting-owner rows connected to Beta Bionics, Inc.. Open a relationship link for the CIK-to-CIK filing trail.
Rows
12
Largest Forms 3/4/5 holder
Sean Saint
Net 12M change
-$4,034,755
Latest report
14 Sep 2026
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Sean Saint | President & CEO, Director | $7,999,577 | -$744,510 | -8.5% | Filing P/S | 03 Sep 2026 |
| Mike Mensinger | Chief Product Officer | $3,441,122 | -$467,169 | -12% | Filing P/S | 02 Sep 2026 |
| Steven Jon Russell | Chief Medical Officer | $3,242,116 | -$163,973 | -4.8% | Filing P/S | 02 Sep 2026 |
| Stephen Feider | Chief Financial Officer | $3,046,207 | -$1,434,557 | -32% | Filing P/S | 02 Sep 2026 |
| Mark Hopman | Chief Commercial Officer | $1,340,648 | -$964,376 | -42% | Filing P/S | 14 Sep 2026 |
| Adam Lezack | Director | $591,679 | -$100,460 | -15% | Mixed | 21 May 2026 |
| Christy Jones | Director | $389,910 | -$80,324 | -17% | Filing P/S | 24 Jun 2026 |
| Gerard J. Michel | Director | $335,760 | Mixed | 21 May 2026 | ||
| Danny L. Dearen | Director | $322,734 | Mixed | 21 May 2026 | ||
| Sean Carney | Director | $322,734 | Mixed | 21 May 2026 | ||
| Maria Palasis | Director | $294,557 | -$79,386 | -21% | Mixed | 21 May 2026 |
| Wellington Hadley Harbor Aggregator IV, L.P. | 10%+ Owner | $78,032 | Filing P/S | 31 Jan 2025 |
Recent insider transactions for Beta Bionics, Inc.
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Mark Hopman | BBNX | Common Stock | Sale | -0.89% | $12,028 | $15.52 | -775 | 86,382 | 14 Sep 2026 | Direct |
| Mark Hopman | BBNX | Common Stock | Sale | -29.7% | $680,723 | $18.46 | -36,870 | 87,157 | 09 Sep 2026 | Direct |
| Sean Saint | BBNX | Common Stock | Sale | -1.4% | $113,259 | $20.08 | -5,641 | 398,429 | 03 Sep 2026 | Direct |
| Mark Hopman | BBNX | Common Stock | Sale | -4.12% | $101,815 | $19.11 | -5,327 | 124,027 | 02 Sep 2026 | Direct |
| Steven Jon Russell | BBNX | Common Stock | Sale | -2.43% | $80,676 | $19.11 | -4,221 | 169,628 | 02 Sep 2026 | Direct |
| Mike Mensinger | BBNX | Common Stock | Sale | -2.37% | $83,620 | $19.11 | -4,375 | 180,040 | 02 Sep 2026 | Direct |
| Stephen Feider | BBNX | Common Stock | Sale | -4.02% | $127,580 | $19.11 | -6,675 | 159,378 | 02 Sep 2026 | Direct |
| Sean Saint | BBNX | Common Stock | Sale | -4.01% | $322,381 | $19.11 | -16,867 | 404,070 | 02 Sep 2026 | Direct |
| Stephen Feider | BBNX | Common Stock | Sale | -2.86% | $83,381 | $17.03 | -4,896 | 166,053 | 29 Jun 2026 | Direct |
| Stephen Feider | BBNX | Common Stock | Options Exercise | 2.95% | 4,896 | 170,949 | 29 Jun 2026 | Direct | ||
| Stephen Feider | BBNX | Employee Stock Option (right to buy) | Options Exercise | -11% | -4,896 | 39,695 | 29 Jun 2026 | Direct | ||
| Stephen Feider | BBNX | Common Stock | Sale | -2.98% | $87,006 | $17.05 | -5,104 | 166,053 | 26 Jun 2026 | Direct |
| Stephen Feider | BBNX | Common Stock | Options Exercise | 3.07% | 5,104 | 171,157 | 26 Jun 2026 | Direct | ||
| Stephen Feider | BBNX | Employee Stock Option (right to buy) | Options Exercise | -10.3% | -5,104 | 44,591 | 26 Jun 2026 | Direct | ||
| Mark Hopman | BBNX | Common Stock | Sale | -0.96% | $18,880 | $15.01 | -1,258 | 129,354 | 24 Jun 2026 | Direct |
| Christy Jones | BBNX | Common Stock | Sale | -5.13% | $21,090 | $15.00 | -1,406 | 25,994 | 24 Jun 2026 | Direct |
| Mark Hopman | BBNX | Common Stock | Sale | -0.21% | $3,385 | $12.31 | -275 | 130,612 | 04 Jun 2026 | Direct |
| Christy Jones | BBNX | Common Stock | Sale | -9.3% | $39,354 | $14.00 | -2,811 | 27,400 | 04 Jun 2026 | Direct |
| Mike Mensinger | BBNX | Common Stock | Sale | -2.32% | $55,194 | $12.61 | -4,378 | 184,415 | 02 Jun 2026 | Direct |
| Mark Hopman | BBNX | Common Stock | Sale | -3.91% | $67,183 | $12.61 | -5,329 | 130,887 | 02 Jun 2026 | Direct |
| Steven Jon Russell | BBNX | Common Stock | Sale | -2.37% | $53,227 | $12.61 | -4,222 | 173,849 | 02 Jun 2026 | Direct |
| Stephen Feider | BBNX | Common Stock | Sale | -3.87% | $84,165 | $12.61 | -6,676 | 166,053 | 02 Jun 2026 | Direct |
| Sean Saint | BBNX | Common Stock | Sale | -3.85% | $212,707 | $12.61 | -16,872 | 420,937 | 02 Jun 2026 | Direct |
| Adam Lezack | BBNX | Comon Stock | Sale | -3.51% | $11,188 | $11.21 | -998 | 27,399 | 22 May 2026 | Direct |
| Gerard J. Michel | BBNX | Common Stock | Award | 102.5% | 16,965 | 33,509 | 21 May 2026 | Direct | ||
| Christy Jones | BBNX | Common Stock | Award | 128.1% | 16,965 | 30,211 | 21 May 2026 | Direct | ||
| Christy Jones | BBNX | Common Stock | Sale | -13.1% | $19,880 | $9.95 | -1,998 | 13,246 | 21 May 2026 | Direct |
| Maria Palasis | BBNX | Common Stock | Award | 136.5% | 16,965 | 29,397 | 21 May 2026 | Direct | ||
| Danny L. Dearen | BBNX | Common Stock | Award | 111.3% | 16,965 | 32,209 | 21 May 2026 | Direct | ||
| Sean Carney | BBNX | Common Stock | Award | 111.3% | 16,965 | 32,209 | 21 May 2026 | Direct | ||
| Adam Lezack | BBNX | Common Stock | Award | 148.4% | 16,965 | 28,397 | 21 May 2026 | Direct | ||
| Adam Lezack | BBNX | Common Stock | Sale | -8.04% | $9,950 | $9.95 | -1,000 | 11,432 | 21 May 2026 | Direct |
| Mark Hopman | BBNX | Common Stock | Sale | -0.25% | $4,084 | $11.57 | -353 | 139,133 | 04 Mar 2026 | Direct |
| Mike Mensinger | BBNX | Employee Stock Option (right to buy) | Award | 91,520 | 91,520 | 27 Feb 2026 | Direct | |||
| Steven Jon Russell | BBNX | Employee Stock Option (right to buy) | Award | 91,520 | 91,520 | 27 Feb 2026 | Direct | |||
| Sean Saint | BBNX | Employee Stock Option (right to buy) | Award | 287,944 | 287,944 | 27 Feb 2026 | Direct | |||
| Mark Hopman | BBNX | Employee Stock Option (right to buy) | Award | 91,520 | 91,520 | 27 Feb 2026 | Direct | |||
| Stephen Feider | BBNX | Employee Stock Option (right to buy) | Award | 110,342 | 110,342 | 27 Feb 2026 | Direct | |||
| Gerard J. Michel | BBNX | Common Stock | Award | 31.9% | 3,997 | 16,544 | 13 Jan 2026 | Direct | ||
| Sean Carney | BBNX | Common Stock | Award | 35.5% | 3,997 | 15,244 | 13 Jan 2026 | Direct | ||
| Maria Palasis | BBNX | Common Stock | Award | 47.4% | 3,997 | 12,432 | 13 Jan 2026 | Direct | ||
| Christy Jones | BBNX | Common Stock | Award | 35.5% | 3,997 | 15,244 | 13 Jan 2026 | Direct | ||
| Adam Lezack | BBNX | Common Stock | Award | 47.4% | 3,997 | 12,432 | 13 Jan 2026 | Direct | ||
| Danny L. Dearen | BBNX | Common Stock | Award | 35.5% | 3,997 | 15,244 | 13 Jan 2026 | Direct | ||
| Mike Mensinger | BBNX | Common Stock | Sale | -2.65% | $66,221 | $30.10 | -2,200 | 80,752 | 06 Jan 2026 | Direct |
| Mike Mensinger | BBNX | Common Stock | Sale | -8.59% | $230,950 | $29.61 | -7,800 | 82,952 | 02 Jan 2026 | Direct |
| Stephen Feider | BBNX | Common Stock | Sale | -31.9% | $590,680 | $29.53 | -20,000 | 42,614 | 02 Jan 2026 | Direct |
| Stephen Feider | BBNX | Common Stock | Options Exercise | 46.9% | 20,000 | 62,614 | 02 Jan 2026 | Direct | ||
| Stephen Feider | BBNX | Employee Stock Option (right to buy) | Options Exercise | -28.7% | -20,000 | 49,695 | 02 Jan 2026 | Direct | ||
| Mark Hopman | BBNX | Common Stock | Sale | -1.49% | $63,192 | $30.66 | -2,061 | 136,216 | 04 Dec 2025 | Direct |
* marks a reported price that did not pass the local price check.